 Zacks Investment Research lowered shares of InspireMD NYSEAMERICAN:NSPR from a buy rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuardTM. The Companys initial products are ... 